期刊文献+

丙硫氧嘧啶治疗妊娠合并甲亢的疗效及对妊娠结局的影响研究 被引量:7

Therapeutic effect of propylthiouracil on pregnancy with hyperthyroidism and its effect on pregnancy outcome
下载PDF
导出
摘要 目的:研究分析将丙硫氧嘧啶运用到妊娠合并甲亢中的疗效及对妊娠结局的影响。方法:从我院2014年1月-2017年1月收治的妊娠合并甲亢患者中选取40例为研究组,使用药物为丙硫氧嘧啶;选取同时期在我院确诊为妊娠合并甲亢患者40例对照组,未接受药物治疗。将两组患者的相关临床指标以及妊娠结局进行对比分析。结果:研究组的各项相关临床指标(包括促甲状腺激素、总甲状腺素、游离甲状腺素、总三碘甲状腺原氨酸以及游离三碘甲状腺原氨酸)均优于对照组且更接近正常水平,差异具有统计学意义(P <0.05);研究组中共有2例患者妊娠结局不良,其发生率为5.0%,对照组中则有16例患者妊娠结局不良,其发生率为40.0%,两组妊娠结局差异具有统计学意义(P <0.05)。结论:将丙硫氧嘧啶运用到妊娠合并甲亢的治疗中可以有效改善患者的相关临床指标,将其控制在标准范围内,同时可以有效地改善患者的妊娠结局。 Objective: To analyze the efficacy of propylthiouracil on pregnancy with hyperthyroidism and its effect on pregnancy outcome. Methods: 40 patients with pregnancy and hyperthyroidism were enrolled in the study group and treated with propylthiouracil. 40 patients in the same period were selected as the control group and did not receive medical treatment. The clinical indicators and pregnancy outcomes in two groups were compared and analyzed. Results:The relevant clinical indicators (including thyroid stimulating hormone, total thyroxine, free thyroxine, total triiodothyronine and free triiodothyronine) in the study group were superior to the control group and closer to normal levels. The difference was statistically significant (P〈0.05). There were 2 cases (5.0%) in the study group with poor pregnancy outcome, and 16 cases (40.0%) in the control group had poor pregnancy outcome, the difference is statistically significant (P〈0.05). Conclusion: Propylthiouracil can effectively improve the clinical indicators of patients with hyperthyroidism in pregnancy, control it within the standard range, and can effectively improve the pregnancy outcome of patients.
机构地区 东莞市长安医院
出处 《中医临床研究》 2018年第32期87-89,共3页 Clinical Journal Of Chinese Medicine
关键词 丙硫氧嘧啶 妊娠合并甲亢 妊娠结局 Propylthiouracil Pregnancy with hyperthyroidism Pregnancy outcome
  • 相关文献

参考文献8

二级参考文献106

  • 1张扬,江霞.他巴唑与丙基硫氧嘧啶治疗甲状腺功能亢进症的效果比较[J].包头医学院学报,2006,22(3):270-271. 被引量:4
  • 2中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:835
  • 3谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 4朱大年.生理学[M].8版.北京:人民卫生出版社,2013:367-368.
  • 5Cassina M, Dond M, Di Gianantonio E, et al. Pharmacologic treatment of hyperthyroidism during pregnancy. Birth defects research. Birth Defects Res A Clin Mol Terato, 2012, 94(8) : 612- 619.
  • 6Pillar N, Levy A, Holcberg G, et al. Pregnancy and perinatal outcome in women with hyperthyroidism. Int J Gynaecol Obstet, 2010,108(1) : 61-64.
  • 7Nakamura H, Noh J Y, Itoh K, et al. Comparison of methimazole and propyhhiouracil in patients with hyperthyroidism under caused by Graves' diseases. J Clin Endocrinol Metab, 2007, 95 (6) : 2157-2162.
  • 8沈晓明,王卫平.儿科学[M].7版.北京:人民卫生出版社,2008:251.
  • 9Glinoer D, Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny[J]. Thyroid, 2000,10(10):871-887.
  • 10Thorpe-Beeston JG, Nicolaides KH, Felton CV, et al. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus[J]. N Engl J Med, 1991,324(8):532-536.

共引文献174

同被引文献51

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部